e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Asthma: animal models
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Regulated lung-specific overexpression of nitric oxide induces airway hyperresponsiveness in mice
J. Hjoberg, J. M. Drazen, J. A. Elias, L. Kobzik, S. Shore, I. Schwartzman, E. S. Silverman (Boston, New Haven, United States Of America)
Source:
Annual Congress 2002 - Asthma: animal models
Session:
Asthma: animal models
Session type:
Oral Presentation
Number:
3521
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Hjoberg, J. M. Drazen, J. A. Elias, L. Kobzik, S. Shore, I. Schwartzman, E. S. Silverman (Boston, New Haven, United States Of America). Regulated lung-specific overexpression of nitric oxide induces airway hyperresponsiveness in mice. Eur Respir J 2002; 20: Suppl. 38, 3521
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Inhibitors of NADPH-oxidase or nitric oxide synthase prevent airway hyperresponsiveness but not allergic inflammation in mice
Source: Eur Respir J 2001; 18: Suppl. 33, 265s
Year: 2001
Lactose-β-sitosterol inhibits ovalbumin-induced asthmatic inflammation with no influence on nitric oxide pathway
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Inducible nitric oxide synthase inhibition modulates lung tissue extracellular matrix remodelling induced by chronic allergic inflammation
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen
Source: Eur Respir J 2003; 21: 394-400
Year: 2003
Grape seed proanthocyanidin extract attenuates airway inflammation and hyperresponsiveness in a murine model of asthma: Downregulating inducible nitric oxide synthase
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response
Source: Eur Respir J 2002; 20: 609-616
Year: 2002
Neurokinins and nitric oxide modulate airway remodeling in a model of lung allergic inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 578s
Year: 2005
Nitric oxide (NO) modulates ICAM-1 expression and function and MCP-1 secretion in human airway epithelium
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005
Augmented lower respiratory tract nitric oxide production in eNOS deficient mice is related to upregulation of pulmonary iNOS expression
Source: Eur Respir J 2001; 18: Suppl. 33, 253s
Year: 2001
Airway and systemic nitric oxide pathway in COPD
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Source: Eur Respir J 2006; 27: 1152-1159
Year: 2006
Increased nitric oxide production by neutrophils in bronchial asthma
Source: Eur Respir J 2001; 17: 868-871
Year: 2001
Chronic nitric oxide inhibition increases airway remodeling in guinea pigs with lung inflammation
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004
Expression of inducible nitiric oxide synthase (iNOS) in airway epithelial cells is reduced in young children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 231s
Year: 2003
Different effects of cNOS and iNOS-derived nitric oxide in lung mechanics in a model of chronic airway inflammation in guinea pigs: modulation by neuropeptides
Source: Eur Respir J 2005; 26: Suppl. 49, 558s
Year: 2005
Methacholine airway hyperresponsiveness is associated with fraction of nitric oxide irrespective of asthma
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012
Modulation of chronic airway inflammation by oral tolerance: effects in lung mechanics, exhaled nitric oxide and airway hyperresponsiveness to methacholine in guinea pigs
Source: Eur Respir J 2003; 22: Suppl. 45, 484s
Year: 2003
Decreased airway eosinophilic inflammation, hypersecretion and remodeling in mice lacking all nitric oxide synthase isoforms
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept